| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antilymphocyte-antibody prophylaxis: Review of the adult experience in heart transplantation
|
Taylor, D.O.
|
|
1997
|
|
8S1 |
p. 13S-15S
nvt p.
|
artikel
|
| 2 |
Anti-T-cell-antibody prophylaxis in children: Success with a novel combination strategy of mycophenolate mofetil and antithymocyte serum
|
Boucek, M.M.
|
|
1997
|
|
8S1 |
p. 16S-20S
nvt p.
|
artikel
|
| 3 |
Approaches to improving long-term allograft outcome
|
Vanrenterghem, Y.F
|
|
1998
|
|
8S1 |
p. 2S-6S
nvt p.
|
artikel
|
| 4 |
Can histopathology guide immunosuppression for cardiac allograft rejection in the light of new techniques?
|
Billingham, M.E.
|
|
1997
|
|
8S1 |
p. 35S-36S
nvt p.
|
artikel
|
| 5 |
Choice of immunosuppressive drugs and individualization of immunosuppressive therapy for kidney transplant patients
|
Danovitch, G.M
|
|
1999
|
|
8S1 |
p. 2-6
5 p.
|
artikel
|
| 6 |
Chronic allograft nephropathy: nonimmunologic risk factors
|
Weir, M.R.
|
|
1998
|
|
8S1 |
p. 20S-24S
nvt p.
|
artikel
|
| 7 |
Clinical role of immunologic monitoring during OKT3 treatment
|
Bhat, G.
|
|
1997
|
|
8S1 |
p. 21S-26S
nvt p.
|
artikel
|
| 8 |
Designing studies to measure the benefit of low-toxicity regimens
|
Halloran, P.F
|
|
1998
|
|
8S1 |
p. 25S-29S
nvt p.
|
artikel
|
| 9 |
Editorial
|
|
|
1998
|
|
8S1 |
p. 1S-
1 p.
|
artikel
|
| 10 |
Foreword
|
Kasiske, Bertram
|
|
1999
|
|
8S1 |
p. 1-
1 p.
|
artikel
|
| 11 |
Iatrogenic problems caused by immunosuppressive drugs in transplant recipients
|
Sells, R.A
|
|
1998
|
|
8S1 |
p. 14S-19S
nvt p.
|
artikel
|
| 12 |
Immunosuppressive drug-induced toxicities compromising the half-life of renal allografts
|
Paul, L.C.
|
|
1998
|
|
8S1 |
p. 7S-13S
nvt p.
|
artikel
|
| 13 |
Individualizing immunosuppression for heart transplantation: Strategies for the next decade
|
Valantine, H.A.
|
|
1997
|
|
8S1 |
p. 5S-8S
nvt p.
|
artikel
|
| 14 |
Mycophenolate mofetil-based immunosuppressive therapy: induction, maintenance, and conversion protocols in renal transplantation
|
Land, W.
|
|
1999
|
|
8S1 |
p. 27-32
6 p.
|
artikel
|
| 15 |
Potential utility of rapamycin and tacrolimus in long-term, low-toxicity regimens
|
Gaston, R.S
|
|
1999
|
|
8S1 |
p. 17-22
6 p.
|
artikel
|
| 16 |
Progress with cyclosporine-sparing regimens
|
Grinyó, J.M.
|
|
1999
|
|
8S1 |
p. 11-16
6 p.
|
artikel
|
| 17 |
Recurrent or persistent cardiac allograft rejection: Therapeutic options and recommendations
|
Kirklin, J.K.
|
|
1997
|
|
8S1 |
p. 40S-44S
nvt p.
|
artikel
|
| 18 |
Strategies to reduce or replace steroid dosing
|
Vanrenterghem, Y
|
|
1999
|
|
8S1 |
p. 7-10
4 p.
|
artikel
|
| 19 |
Targeting nonalloimmune-dependent pathways
|
Kobashigawa, J.A.
|
|
1997
|
|
8S1 |
p. 47S-50S
nvt p.
|
artikel
|
| 20 |
Targeting the alloimmune response for prevention of chronic graft loss: Efficacy of new immunosuppressive drugs
|
Eisen, H.J.
|
|
1997
|
|
8S1 |
p. 29S-31S
nvt p.
|
artikel
|
| 21 |
The immune system's role in graft loss: Theoretic considerations
|
Matzinger, P.
|
|
1997
|
|
8S1 |
p. 11S-12S
nvt p.
|
artikel
|
| 22 |
The interleukin-2 inhibitors and their role in low-toxicity regimens
|
Nashan, B
|
|
1999
|
|
8S1 |
p. 23-26
4 p.
|
artikel
|
| 23 |
Treatment of nonhemodynamic compromising rejection: Conventional approaches Vs individualization/new immunosuppressive drugs
|
Kobashigawa, J.A.
|
|
1997
|
|
8S1 |
p. 37S-39S
nvt p.
|
artikel
|
Tijdschrift beschrijving